Skip to main content

ADVERTISEMENT

Hauro Hirayama, MD, PhD

Original Contribution
08/29/2012
Abstract: To address safety concerns with first-generation drug-eluting stents (DESs), the everolimus-eluting stent (EES) has been developed as a second-generation DES. The study aim was to: (1) demonstrate that use of the EES in Japanese...
Abstract: To address safety concerns with first-generation drug-eluting stents (DESs), the everolimus-eluting stent (EES) has been developed as a second-generation DES. The study aim was to: (1) demonstrate that use of the EES in Japanese...
Abstract: To address safety...
08/29/2012
Journal of Invasive Cardiology
Review
03/27/2012
Abstract: In-stent restenosis has been a longstanding problem after percutaneous coronary intervention. The introduction of the drug-eluting stent (DES) successfully reduced the rate of restenosis; however, it is not completely diminished....
Abstract: In-stent restenosis has been a longstanding problem after percutaneous coronary intervention. The introduction of the drug-eluting stent (DES) successfully reduced the rate of restenosis; however, it is not completely diminished....
Abstract: In-stent restenosis...
03/27/2012
Journal of Invasive Cardiology